Mice deficient in tumor necrosis factor-α are resistant to skin carcinogenesis
The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
Given the associations between chronic inflammation and epithelial cancer, we studied susceptibility to skin carcinogenesis in mice deficient for the pro-inflammatory cytokine TNF-alpha (refs. 5,6). TNF-alpha(-/-) mice were resistant to development of benign and malignant skin tumors, whether induced by initiation with DMBA and promotion with TPA or by repeated dosing with DMBA. TNF-alpha(-/-) mice developed 5-10% the number of tumors developed by wild-type mice during initiation/promotion and 25% of those in wild-type mice after repeated carcinogen treatment. TNF-alpha could influence tumor and stromal cells during tumor development. The early stages of TPA promotion are characterized by keratinocyte hyperproliferation and inflammation. These were diminished in TNF-alpha(-/-) mice. TNF-alpha was extensively induced in the epidermis, but not the dermis, in TPA-treated wild-type skin, indicating that dermal inflammation is controlled by keratinocyte TNF-alpha production. Deletion of a TNF-alpha inducible chemokine also conferred some resistance to skin tumor development. TNF-alpha has little influence on later stages of carcinogenesis, as tumors in wild-type and TNF-alpha(-/-) mice had similar rates of malignant progression. These data provide evidence that a pro-inflammatory cytokine is required for de novo carcinogenesis and that TNF-alpha is important to the early stages of tumor promotion. Strategies that neutralize TNF-alpha production may be useful in cancer treatment an…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“MCP1 is a critical chemoattractant responsible for the recruitment of macrophages into tumor and for angiogenesis in breast cancer [131, 132], and may contribute to indirect crosstalk between MSC and cancer cells via recruitment of tumor-resident macrophages.”
From Mesenchymal stem cell secretome and regenerative therapy after cancer (2013) · cites this paper as [132]
Citations
Cites
Measurement of Cutaneous Inflammation: Estimation of Neutrophil Content with an Enzyme Marker
Bradley, P. P., Priebat, D. A., Christensen, R. D., & Rothstein, G. (1982) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12506462 · Cited by 3,626
Correa, P. (1992) · PubMed · Cited by 3,216
Wilson, A. G., Symons, J. A., McDowell, T. L., McDevitt, H. O., & Duff, G. W. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.7.3195 · Cited by 2,218
Pasparakis, M., Alexopoulou, L., Episkopou, V, & Kollias, G. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.4.1397 · Cited by 1,160
Self-citationLu, B., Rutledge, B. J., Gu, L., Fiorillo, J., Lukacs, N. W., Kunkel, S. L., North, R., Gerard, C., & Rollins, B. J. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.4.601 · Cited by 1,017
Self-citationEggermont, A. M., Schraffordt Koops, H., Liénard, D., Kroon, B. B., van Geel, A. N., Hoekstra, H. J., & Lejeune, F. J. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.10.2653 · Cited by 398
Genetic Polymorphisms in the Tumor Necrosis Factor Locus Influence Non-Hodgkin's Lymphoma Outcome
Warzocha, K., Ribeiro, P., Bienvenu, J., Roy, P., Charlot, C., Rigal, D., Coiffier, B., & Salles, G. (1998) · Blood · doi:10.1182/blood.v91.10.3574 · Cited by 272
Naylor, M. S., Stamp, G. W., Foulkes, W. D., Eccles, D., & Balkwill, F. R. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116446 · Cited by 252
Self-citationAnti-Tumor Necrosis Factor-α Therapy of Rheumatoid Arthritis
Feldmann, M., Elliott, M. J., Maini, R. N., & Woody, J. N. (1997) · Advances in Immunology · doi:10.1016/s0065-2776(08)60891-3 · Cited by 230
Pasparakis, M., Alexopoulou, L., Grell, M., Pfizenmaier, K., Bluethmann, H., & Kollias, G. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.12.6319 · Cited by 205
Self-citation
Cited by
Items 101–200 of 838
Maniati, E., Bossard, M., Cook, N., Candido, J. B., Emami-Shahri, N., Nedospasov, S. A., Balkwill, F. R., Tuveson, D. A., & Hagemann, T. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45797 · Cited by 248
Self-citationSaijo, Y., Tanaka, M., Miki, M., Usui, K., Suzuki, T., Maemondo, M., Hong, X., Tazawa, R., Kikuchi, T., Matsushima, K., et al. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.1.469 · Cited by 249
Cellular and molecular pathways linking inflammation and cancer
Porta, C., Larghi, P., Rimoldi, M., Grazia Totaro, M., Allavena, P., Mantovani, A., & Sica, A. (2009) · Immunobiology · doi:10.1016/j.imbio.2009.06.014 · Cited by 250
B cell regulation of the anti-tumor response and role in carcinogenesis
Schwartz, M., Zhang, Y., & Rosenblatt, J. D. (2016) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-016-0145-x · Cited by 244
Oncogenic Ras Diverts a Host TNF Tumor Suppressor Activity into Tumor Promoter
Cordero, J. B., Macagno, J. P., Stefanatos, R. K., Strathdee, K. E., Cagan, R. L., & Vidal, M. (2010) · Developmental Cell · doi:10.1016/j.devcel.2010.05.014 · Cited by 239
Tumors and inflammatory infiltrates: Friends or foes?
Brigati, C., Noonan, D. M., Albini, A., & Benelli, R. (2002) · Clinical & Experimental Metastasis · doi:10.1023/a:1015587423262 · Cited by 230
Mercer, L. K., Lunt, M., Low, A. L. S., Dixon, W. G., Watson, K. D., Symmons, D. P. M., Hyrich, K. L., Maiden, N., Price, T., Hopkinson, N., et al. (2015) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-204851 · Cited by 226
Positive feedback between NF-κB and TNF-α promotes leukemia-initiating cell capacity
Kagoya, Y., Yoshimi, A., Kataoka, K., Nakagawa, M., Kumano, K., Arai, S., Kobayashi, H., Saito, T., Iwakura, Y., & Kurokawa, M. (2014) · Journal of Clinical Investigation · doi:10.1172/jci68101 · Cited by 227
TNF-α is critical for antitumor but not antiviral T cell immunity in mice
Calzascia, T., Pellegrini, M., Hall, H., Sabbagh, L., Ono, N., Elford, A. R., Mak, T. W., & Ohashi, P. S. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32567 · Cited by 224
Smith, M. P., Sanchez-Laorden, B., O'Brien, K., Brunton, H., Ferguson, J., Young, H., Dhomen, N., Flaherty, K. T., Frederick, D. T., Cooper, Z. A., et al. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-1007 · Cited by 223
Mignogna, M. D., Fedele, S., Lo Russo, L., Lo Muzio, L., & Bucci, E. (2004) · Oral Oncology · doi:10.1016/j.oraloncology.2003.08.001 · Cited by 221
TLR-signaling and proinflammatory cytokines as drivers of tumorigenesis
Korneev, K. V., Atretkhany, K.-S. N., Drutskaya, M. S., Grivennikov, S. I., Kuprash, D. V., & Nedospasov, S. A. (2017) · Cytokine · doi:10.1016/j.cyto.2016.01.021 · Cited by 217
Takada, Y., & Aggarwal, B. B. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.6.3278 · Cited by 212
Interleukin-1—a major pleiotropic cytokine in tumor–host interactions
Apte, R. N., & Voronov, E. (2002) · Seminars in Cancer Biology · doi:10.1016/s1044-579x(02)00014-7 · Cited by 212
The Potential Contributions of Chronic Inflammation to Lung Carcinogenesis
Ballaz, S., & Mulshine, J. L. (2003) · Clinical Lung Cancer · doi:10.3816/clc.2003.n.021 · Cited by 212
Expression of both TNF-α receptor subtypes is essential for optimal skin tumour development
Arnott, C. H., Scott, K. A., Moore, R. J., Robinson, S. C., Thompson, R. G., & Balkwill, F. R. (2004) · Oncogene · doi:10.1038/sj.onc.1207317 · Cited by 208
Self-citationCrucial Role of Phospholipase Cε in Chemical Carcinogen-Induced Skin Tumor Development
Bai, Y., Edamatsu, H., Maeda, S., Saito, H., Suzuki, N., Satoh, T., & Kataoka, T. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-3143 · Cited by 206
Evaluation of the association of chronic inflammation and cancer: Insights and implications
Nigam, M., Mishra, A. P., Deb, V. K., Dimri, D. B., Tiwari, V., Bungau, S. G., Bungau, A. F., & Radu, A.-F. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115015 · Cited by 205
Natural mechanisms protecting against cancer
Jakóbisiak, M., Lasek, W., & Gołąb, J. (2003) · Immunology Letters · doi:10.1016/j.imlet.2003.08.005 · Cited by 206
Madhusudan, S., Foster, M., Muthuramalingam, S. R., Braybrooke, J. P., Wilner, S., Kaur, K., Han, C., Hoare, S., Balkwill, F., Talbot, D. C., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0730 · Cited by 205
Self-citationDanese, S., & Mantovani, A. (2010) · Oncogene · doi:10.1038/onc.2010.109 · Cited by 199
The role of metallothionein in oncogenesis and cancer prognosis
Pedersen, M. Ø., Larsen, A., Stoltenberg, M., & Penkowa, M. (2009) · Progress in Histochemistry and Cytochemistry · doi:10.1016/j.proghi.2008.10.001 · Cited by 200
Zhu, S., Yoon, K., Sterneck, E., Johnson, P. F., & Smart, R. C. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.012437299 · Cited by 200
Langerhans Cells: Sensing the Environment in Health and Disease
Deckers, J., Hammad, H., & Hoste, E. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00093 · Cited by 196
Cho, S., Kim, J. S., Kim, J. M., Lee, J. Y., Jung, H. C., & Song, I. S. (2008) · International Journal of Cancer · doi:10.1002/ijc.23593 · Cited by 195
Chronic inflammation and cancer: the role of the mitochondria.
Kamp, D. W., Shacter, E. B., & Weitzman, S. A. (2011) · PubMed · Cited by 239
TLR4‐mediated skin carcinogenesis is dependent on immune and radioresistant cells
Mittal, D., Saccheri, F., Vénéreau, E., Pusterla, T., Bianchi, M. E., & Rescigno, M. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.94 · Cited by 192
Honey as a Potential Natural Anticancer Agent: A Review of Its Mechanisms
Ahmed, S., & Othman, N. H. (2013) · Evidence-Based Complementary and Alternative Medicine · doi:10.1155/2013/829070 · Cited by 191
Cutaneous side effects of anti–tumor necrosis factor biologic therapy: A clinical review
Moustou, A.-E., Matekovits, A., Dessinioti, C., Antoniou, C., Sfikakis, P. P., & Stratigos, A. J. (2009) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2008.10.060 · Cited by 191
Lai, J.-J., Lai, K.-P., Zeng, W., Chuang, K.-H., Altuwaijri, S., & Chang, C. (2012) · The American Journal of Pathology · doi:10.1016/j.ajpath.2012.07.008 · Cited by 188
IL-17 Enhances Tumor Development in Carcinogen-Induced Skin Cancer
Wang, L., Yi, T., Zhang, W., Pardoll, D. M., & Yu, H. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0775 · Cited by 185
Molecular pathways and targets in cancer-related inflammation
Mantovani, A., Garlanda, C., & Allavena, P. (2010) · Annals of Medicine · doi:10.3109/07853890903405753 · Cited by 185
Meng, Y., Beckett, M. A., Liang, H., Mauceri, H. J., van Rooijen, N., Cohen, K. S., & Weichselbaum, R. R. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2995 · Cited by 181
Brown, E. R., Charles, K. A., Hoare, S. A., Rye, R. L., Jodrell, D. I., Aird, R. E., Vora, R., Prabhakar, U., Nakada, M., Corringham, R. E., et al. (2008) · Annals of Oncology · doi:10.1093/annonc/mdn054 · Cited by 181
Self-citationRalGDS is required for tumor formation in a model of skin carcinogenesis
González-García, A., Pritchard, C. A., Paterson, H. F., Mavria, G., Stamp, G., & Marshall, C. J. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.01.029 · Cited by 181
Self-citationTumor Necrosis Factor α Blockade: An Opportunity to Tackle Breast Cancer
Mercogliano, M. F., Bruni, S., Elizalde, P. V., & Schillaci, R. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00584 · Cited by 177
Monk, J. P., Phillips, G., Waite, R., Kuhn, J., Schaaf, L. J., Otterson, G. A., Guttridge, D., Rhoades, C., Shah, M., Criswell, T., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.2838 · Cited by 179
Chen, R., Alvero, A. B., Silasi, D., & Mor, G. (2007) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.2006.00441.x · Cited by 177
Distinct Functions of Neutrophil in Cancer and Its Regulation
Granot, Z., & Jablonska, J. (2015) · Mediators of Inflammation · doi:10.1155/2015/701067 · Cited by 179
Roles of tumor-associated macrophages in tumor progression: implications on therapeutic strategies
Zhu, S., Yi, M., Wu, Y., Dong, B., & Wu, K. (2021) · Experimental Hematology & Oncology · doi:10.1186/s40164-021-00252-z · Cited by 178
Tumour necrosis factor-α in Barrett's oesophagus: a potential novel mechanism of action
Tselepis, C., Perry, I., Dawson, C., Hardy, R., Darnton, S. J., McConkey, C., Stuart, R. C., Wright, N., Harrison, R., & Jankowski, J. A. Z. (2002) · Oncogene · doi:10.1038/sj.onc.1205731 · Cited by 174
The role of cytokines in the epithelial cancer microenvironment
Wilson, J., & Balkwill, F. (2002) · Seminars in Cancer Biology · doi:10.1006/scbi.2001.0419 · Cited by 174
Self-citationTransmembrane TNF-α Promotes Suppressive Activities of Myeloid-Derived Suppressor Cells via TNFR2
Hu, X., Li, B., Li, X., Zhao, X., Wan, L., Lin, G., Yu, M., Wang, J., Jiang, X., Feng, W., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1203195 · Cited by 172
Mesenchymal stem cell secretome and regenerative therapy after cancer
Zimmerlin, L., Park, T. S., Zambidis, E. T., Donnenberg, V. S., & Donnenberg, A. D. (2013) · Biochimie · doi:10.1016/j.biochi.2013.05.010 · Cited by 168
Inflammation in epithelial skin tumours: Old stories and new ideas
Mueller, M. M. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2006.01.014 · Cited by 170
Prevention of human cancer by modulation of chronic inflammatory processes
Ohshima, H., Tazawa, H., Sylla, B. S., & Sawa, T. (2005) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2005.03.030 · Cited by 169
Study of Etanercept, a Tumor Necrosis Factor-Alpha Inhibitor, in Recurrent Ovarian Cancer
Madhusudan, S., Muthuramalingam, S. R., Braybrooke, J. P., Wilner, S., Kaur, K., Han, C., Hoare, S., Balkwill, F., & Ganesan, T. S. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.127 · Cited by 167
Self-citationChronic immune activation and inflammation in the pathogenesis of aids and cancer
(2002) · Advances in Cancer Research · doi:10.1016/s0065-230x(02)84008-8 · Cited by 166
Promising molecular targets for cancer prevention: AP-1, NF-κB and Pdcd4
Young, M. R., Yang, H.-S., & Colburn, N. H. (2003) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(02)00009-6 · Cited by 166
Tumour necrosis factor-α mediates tumour promotion via a PKCα- and AP-1-dependent pathway
Arnott, C. H., Scott, K. A., Moore, R. J., Hewer, A., Phillips, D. H., Parker, P., Balkwill, F. R., & Owens, D. M. (2002) · Oncogene · doi:10.1038/sj.onc.1205588 · Cited by 165
Self-citationJang, W. H., Yang, Y.-I., Yea, S. S., Lee, Y. J., Chun, J. H., Kim, H.-I., Kim, M. S., & Paik, K.-H. (2001) · Cancer Letters · doi:10.1016/s0304-3835(01)00438-4 · Cited by 165
Tumor Necrosis Factor-α Is a Potent Endogenous Mutagen that Promotes Cellular Transformation
Yan, B., Wang, H., Rabbani, Z. N., Zhao, Y., Li, W., Yuan, Y., Li, F., Dewhirst, M. W., & Li, C.-Y. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-2540 · Cited by 165
Onizawa, M., Nagaishi, T., Kanai, T., Nagano, K.-I., Oshima, S., Nemoto, Y., Yoshioka, A., Totsuka, T., Okamoto, R., Nakamura, T., et al. (2009) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00071.2008 · Cited by 163
Shurin, M. R., Shurin, G. V., Lokshin, A., Yurkovetsky, Z. R., Gutkin, D. W., Chatta, G., Zhong, H., Han, B., & Ferris, R. L. (2006) · Cancer and Metastasis Reviews · doi:10.1007/s10555-006-9010-6 · Cited by 163
Cellular aspects of photocarcinogenesis
Nishigori, C. (2006) · Photochemical & Photobiological Sciences · doi:10.1039/b507471a · Cited by 161
Tumor-Elicited Inflammation and Colorectal Cancer
(2015) · Advances in Cancer Research · doi:10.1016/bs.acr.2015.04.014 · Cited by 161
Inflammation and cancer: Breast cancer as a prototype
Mantovani, A., Marchesi, F., Porta, C., Sica, A., & Allavena, P. (2007) · The Breast · doi:10.1016/j.breast.2007.07.013 · Cited by 159
Heparanase and the hallmarks of cancer
Jayatilleke, K. M., & Hulett, M. D. (2020) · Journal of Translational Medicine · doi:10.1186/s12967-020-02624-1 · Cited by 181
IL-23 suppresses innate immune response independently of IL-17A during carcinogenesis and metastasis
Teng, M. W. L., Andrews, D. M., McLaughlin, N., von Scheidt, B., Ngiow, S. F., Möller, A., Hill, G. R., Iwakura, Y., Oft, M., & Smyth, M. J. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1003251107 · Cited by 156
TNF in the era of immune checkpoint inhibitors: friend or foe?
Chen, A. Y., Wolchok, J. D., & Bass, A. R. (2021) · Nature Reviews Rheumatology · doi:10.1038/s41584-021-00584-4 · Cited by 183
The role of AP-1, NF-κB and ROS/NOS in skin carcinogenesis: The JB6 model is predictive
Dhar, A., Young, M. R., & Colburn, N. H. (2002) · Molecular and Cellular Biochemistry · doi:10.1023/a:1015948505117 · Cited by 156
Murakawa, M., Yamaoka, K., Tanaka, Y., & Fukuda, Y. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.01.005 · Cited by 159
Oshima, H., Ishikawa, T., Yoshida, G. J., Naoi, K., Maeda, Y., Naka, K., Ju, X., Yamada, Y. M. A., Minamoto, T., Mukaida, N., et al. (2013) · Oncogene · doi:10.1038/onc.2013.356 · Cited by 172
Anti-Inflammatory Plant Natural Products for Cancer Therapy
Kandan, A., & Yang, N. (2010) · Planta Medica · doi:10.1055/s-0030-1249859 · Cited by 172
Kulbe, H., Hagemann, T., Szlosarek, P. W., Balkwill, F. R., & Wilson, J. L. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0957 · Cited by 153
Self-citationHaridas, V., Arntzen, C. J., & Gutterman, J. U. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191363498 · Cited by 154
TAK1 Is a Master Regulator of Epidermal Homeostasis Involving Skin Inflammation and Apoptosis
Omori, E., Matsumoto, K., Sanjo, H., Sato, S., Akira, S., Smart, R. C., & Ninomiya-Tsuji, J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603384200 · Cited by 153
The effect of environmental chemicals on the tumor microenvironment
Casey, S. C., Vaccari, M., Al-Mulla, F., Al-Temaimi, R., Amedei, A., Barcellos-Hoff, M. H., Brown, D. G., Chapellier, M., Christopher, J., Curran, C. S., et al. (2015) · Carcinogenesis · doi:10.1093/carcin/bgv035 · Cited by 152
Macrophage infiltration in human non-small-cell lung cancer: the role of CC chemokines
Arenberg, D. A., Keane, M. P., DiGiovine, B., Kunkel, S. L., Strom, S. R. B., Burdick, M. D., Iannettoni, M. D., & Strieter, R. M. (2000) · Cancer Immunology Immunotherapy · doi:10.1007/s002620050603 · Cited by 156
Mechanisms by which inflammation may increase intestinal cancer risk in inflammatory bowel disease
OʼConnor, P. M., Lapointe, T. K., Beck, P. L., & Buret, A. G. (2010) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21217 · Cited by 151
The role of AP-1, NF-кB and ROS/ NOS in skin carcinogenesis: The JB6 model is predictive
Dhar, A., Young, M. R., & Colburn, N. H. (2002) · Springer eBooks · doi:10.1007/978-1-4615-1087-1_21 · Cited by 151
An anti-tumor necrosis factor-alpha antibody inhibits the development of experimental skin tumors.
Scott, K. A., Moore, R. J., Arnott, C. H., East, N., Thompson, R. G., Scallon, B. J., Shealy, D. J., & Balkwill, F. R. (2003) · PubMed · Cited by 168
Self-citationHawighorst, T., Velasco, P., Streit, M., Hong, Y., Kyriakides, T. R., Brown, L. F., Bornstein, P., & Detmar, M. J. (2001) · The EMBO Journal · doi:10.1093/emboj/20.11.2631 · Cited by 148
The atypical chemokine receptor D6 suppresses the development of chemically induced skin tumors
Nibbs, R. J. B., Gilchrist, D. S., King, V., Ferra, A., Forrow, S., Hunter, K. D., & Graham, G. J. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30068 · Cited by 148
Extrinsic regulators of epithelial tumor progression: metalloproteinases
Bergers, G., & Coussens, L. M. (2000) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(99)00043-x · Cited by 161
A Critical Role for Macrophages in Promotion of Urethane-Induced Lung Carcinogenesis
Zaynagetdinov, R., Sherrill, T. P., Polosukhin, V. V., Han, W., Ausborn, J. A., McLoed, A. G., McMahon, F. B., Gleaves, L. A., Degryse, A. L., Stathopoulos, G. T., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100558 · Cited by 147
Ju, W., Wang, X., Shi, H., Chen, W., Belinsky, S. A., & Lin, Y. (2007) · Molecular Pharmacology · doi:10.1124/mol.106.032185 · Cited by 156
Zheng, M., Ekmekçioglu, S., Walch, E. T., Tang, C., & Grimm, E. A. (2004) · Melanoma Research · doi:10.1097/01.cmr.0000129374.76399.19 · Cited by 144
Molecular Mechanisms of Cancer-Induced Sleep Disruption
Walker, W. H., II, & Borniger, J. C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20112780 · Cited by 162
Cancer chemoprevention by phytochemicals: potential molecular targets, biomarkers and animal models
Ki Han, K. W. O. N., Barve, A., Yu, S., Huang, M., & Kong, A. T. (2007) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2007.00694.x · Cited by 165
Multistep skin cancer in mice as a model to study the evolution of cancer cells
Kemp, C. J. (2005) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2005.06.003 · Cited by 159
Pacifico, F., & Leonardi, A. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.07.032 · Cited by 165
NF-κB: arresting a major culprit in cancer
Haefner, B. (2002) · Drug Discovery Today · doi:10.1016/s1359-6446(02)02309-7 · Cited by 154
Modeling Human Cancers in Drosophila
Sonoshita, M., & Cagan, R. L. (2016) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/bs.ctdb.2016.07.008 · Cited by 153
Totzke, J., Gurbani, D., Raphemot, R., Hughes, P. F., Bodoor, K., Carlson, D. A., Loiselle, D. R., Bera, A. K., Eibschutz, L. S., Perkins, M. M., et al. (2017) · Cell chemical biology · doi:10.1016/j.chembiol.2017.07.011 · Cited by 157
Bianchi, A., Silva, I. D. C., Deshpande, N., Singh, S. P., Mehra, S., Garrido, V. T., Guo, X., Nivelo, L. A., Kolonias, D. S., Saigh, S. J., et al. (2023) · Cancer Discovery · doi:10.1158/2159-8290.cd-22-1046 · Cited by 156
Smith, K. J., & Skelton, H. G. (2001) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2001.117725 · Cited by 137
Tumor Necrosis Factor-α Blocks Apoptosis in Melanoma Cells when BRAF Signaling Is Inhibited
Gray-Schopfer, V. C., Karasarides, M., Hayward, R., & Marais, R. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-1880 · Cited by 131
Molecular Mechanisms of Mouse Skin Tumor Promotion
Rundhaug, J. E., & Fischer, S. M. (2010) · Cancers · doi:10.3390/cancers2020436 · Cited by 133
Sangaletti, S., Stoppacciaro, A., Guiducci, C., Torrisi, M. R., & Colombo, M. P. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030202 · Cited by 133
Expression and regulation of tumor necrosis factor α in normal and malignant ovarian epithelium
Szlosarek, P. W., Grimshaw, M. J., Kulbe, H., Wilson, J. L., Wilbanks, G. D., Burke, F., & Balkwill, F. R. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0303 · Cited by 131
Self-citationJee, S., Shen, S., Chiu, H., Tsai, W.-L., & Kuo, M. (2001) · Oncogene · doi:10.1038/sj.onc.1204076 · Cited by 140
Signal transduction pathways: targets for chemoprevention of skin cancer
Bode, A. M., & Dong, Z. (2000) · The Lancet Oncology · doi:10.1016/s1470-2045(00)00029-2 · Cited by 138
Macrophages in the embryo and beyond: Much more than just giant phagocytes
Ovchinnikov, D. A. (2008) · genesis · doi:10.1002/dvg.20417 · Cited by 128
Targeted deletion of the H-ras gene decreases tumor formation in mouse skin carcinogenesis
伊勢, 和., Nakamura, K., Nakao, K., Shimizu, S., Harada, H., Ichise, T., Miyoshi, J., Gondo, Y., Ishikawa, T., Aiba, A., et al. (2000) · Oncogene · doi:10.1038/sj.onc.1203600 · Cited by 132
Chemokines, cytokines and exosomes help tumors to shape inflammatory microenvironment
Атретханы, К.-С. Н., Drutskaya, M. S., Nedospasov, S. A., Grivennikov, S. I., & Kuprash, D. V. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.09.011 · Cited by 138
Zins, K., Abraham, D., Sioud, M., & Aharinejad, S. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2295 · Cited by 126
Iriyama, T., Takeda, K., Nakamura, H. K., Morimoto, Y., Kuroiwa, T., Mizukami, J., Umeda, T., Noguchi, T., Naguro, I., Nishitoh, H., et al. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.32 · Cited by 135
Hewavisenti, R., Arena, J., Ahlenstiel, C., & Sasson, S. C. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1112513 · Cited by 165
Shishodia, S., & Aggarwal, B. B. (2006) · Kluwer Academic Publishers eBooks · doi:10.1007/1-4020-7847-1_8 · Cited by 126
Metadata
- Authors
- Moore, R. J., Owens, D. M., Stamp, G., Arnott, C., Burke, F., East, N., Holdsworth, H., Turner, L., Rollins, B., Pasparakis, M., Kollias, G., & Balkwill, F.
- Affiliations
- Hammersmith Hospital (GB)
- Harvard University (US)
- Pasteur Hellenic Institute (GR)
- Corresponding author
- Balkwill, Frances
- ORCID
- Venue
- Nature Medicine
- Published
- 1999-07
- Volume
- 5
- Issue
- 7
- Pages
- 828-831
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W1585093254
- Cited by
- 839
- References
- 21
- Citations by year
- 2026: 7 · 2025: 11 · 2024: 8 · 2023: 20 · 2022: 15 · 2021: 19 · 2020: 26 · 2019: 18 · 2018: 16 · 2017: 19 · 2016: 37 · 2015: 32 · 2014: 46 · 2013: 44 · 2012: 41
- FWCI
- 12.74
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Keywords
- TNF-α, skin carcinogenesis, TNF-alpha knockout mice, tumor promotion, 7,12-dimethylbenz(a)anthracene, tissue plasminogen activator, keratinocyte hyperproliferation, skin inflammation, chemokines, malignant progression, chronic inflammation and cancer, cancer prevention
- MeSH terms
- Animals, Crosses, Genetic, Female, Immunity, Innate, Male, Mice, Inbred BALB C, Mice, Inbred C57BL, Mice, Inbred Strains, Neoplasm Invasiveness, Neoplasm Staging, Skin, Skin Neoplasms, Tetradecanoylphorbol Acetate, Time Factors, Tumor Necrosis Factor-alpha, 9,10-Dimethyl-1,2-benzanthracene, Mice, Knockout, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.